In exploring downstream effectors of our proposed IDH1mut → D-2-HG ⊣ FTO axis using bioinformatic and biologic experiments, we identified ATF5 (an oncogenic protein involved in proliferation and suppression of apoptosis) as a mediator of glioma growth inhibition. The gene discussed is ATF5; the disease is central nervous system cancer.